GO term ID | GO term (p-value) | Genes up-regulated in parous samples |
---|---|---|
GO:0007044 | cell-substrate junction assembly (0.006) | KRT5, LAMA3, LAMC2 |
GO:0007398 | ectoderm development (0.002) | COL7A1, KRT5, KRT15, LAMA3, LAMC2, NTF4, KLK7 |
GO:0008544 | epidermis development (0.001) | COL7A1, KRT5, KRT15, LAMA3, LAMC2, NTF4, KLK7 |
GO:0010160 | formation of organ boundary(0.009) | NTF4 |
GO:0031581 | hemidesmosome assembly (0.000) | KRT5, LAMA3, LAMC2 |
GO:0016071 | mRNA metabolic process (0.000) | CIRBP, RBMX, HNRNPA1, HNRNPA2B1, HNRNPD, LUC7L3, PNN, PRPF39, RBM25, SFPQ, SFRS1, SFRS5, SFRS7, PABPN1, PRPF4B |
GO:0006397 | mRNA processing (0.000) | RBMX, HNRNPA1, HNRNPA2B1, LUC7L3, PNN, PRPF39, RBM25, SFPQ, SFRS1, SFRS5, SFRS7, PABPN1, PRPF4B |
GO:0034059 | response to anoxia (0.009) | OXTR |
GO:0016070 | RNA metabolic process (0.006) | DDX17, CHD2,C BX3, CIRBP, ZNF785, EZH2, L3MBTL, GATA3, RBMX, ZNF789, HNRNPA1, HNRNPA2B1, HNRNPD, LUC7L3, PNN, PRPF39, ZNF83, METTL3, CREBZF, RBM25, RBBP8, RPS24, CENPK, SFPQ, SFRS1, SFRS5, SFRS7, ZNF814, ZNF207, PABPN1, RUNX3, FUBP1, PRPF4B, HNRPDL |
GO:0006396 | RNA processing (0.000) | DDX17, RBMX, HNRNPA1, HNRNPA2B1, HNRNPD, LUC7L3, PNN, PRPF39, RBM25, RPS24, SFPQ, SFRS1, SFRS5, SFRS7, PABPN1, PRPF4B, HNRPDL |
GO:0008380 | RNA splicing (0.000) | RBMX, HNRNPA1, HNRNPA2B1, HNRNPD, LUC7L3, PNN, PRPF39, RBM25, SFPQ, SFRS1, SFRS5, SFRS7, PABPN1, PRPF4B |
GO term ID | GO term | Genes down-regulated in parous samples |
GO:0032859 | activation of Ral GTPase activity (0.003) | RALGAPA2 |
GO:0021534 | cell proliferation in hindbrain (0.005) | IGF1 |
GO:0009441 | glycolate metabolic process (0.001) | IGF1 |
GO:0042692 | muscle cell differentiation (0.006) | IGF1, SOX6 |
GO:0051450 | myoblast proliferation (0.003) | IGF1 |
GO:0006654 | phosphatidic acid biosynthetic process (0.005) | ABHD5 |
GO:0031325 | positive regulation of cellular metabolic process (0.005) | EBF1, IGF1, ABHD5, SOX6 |
GO:0045821 | positive regulation of glycolysis (0.006) | IGF1 |
GO:0051006 | positive regulation of lipoprotein lipase activity (0.006) | ABHD5 |
GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein (0.009) | IGF1 |
GO:0031329 | regulation of cellular catabolic process (0.002) | IGF1, ABHD5 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway (0.007) | IGF1 |
GO:0010660 | regulation of muscle cell apoptosis (0.006) | IGF1 |
GO:0032485 | regulation of Ral protein signal transduction (0.003) | RALGAPA2 |
GO:0010889 | regulation of sequestering of triglyceride (0.006) | ABHD5 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway (0.010) | IGF1 |
GO:0090207 | regulation of triglyceride metabolic process (0.008) | ABHD5 |
GO:0043403 | skeletal muscle tissue regeneration (0.009) | IGF1 |
GO:0007264 | small GTPase mediated signal transduction (0.005) | IGF1, RASD1, RALGAPA2 |
GO:0035019 | somatic stem cell maintenance (0.010) | IGF1 |